|
|
| | LeterMovir-008-R Basic information |
| Product Name: | LeterMovir-008-R | | Synonyms: | LeterMovir-008-R;LeterMovir-012;4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4R)-;(+/-)-1-METHYLPROPYLAMINE;Methyl (R)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate;methyl 2-[(4R)-8-fluoro-3-[2-methoxy-5-(trifluoromethyl)phenyl]-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3,4-dihydroquinazolin-4-yl]acetate;(E)-methyl 3-(3-fluoro-2-((3-methoxy-3-oxopropyl)amino)phenyl)acrylate;Arginine Impurity 17 Trifluoroacetate(alfa-Keto-Delta-(NG,NG-Dimethylguanidino)valenic Acid Trifluoroacetate) | | CAS: | 917389-34-5 | | MF: | C30H30F4N4O4 | | MW: | 586.58 | | EINECS: | | | Product Categories: | | | Mol File: | 917389-34-5.mol |  |
| | LeterMovir-008-R Chemical Properties |
| Boiling point | 662.2±65.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | pka | 4.85±0.20(Predicted) |
| | LeterMovir-008-R Usage And Synthesis |
| | LeterMovir-008-R Preparation Products And Raw materials |
|